J&J | JNJ - Nettoeinkommen

Aktienkurs
227.35
Täglich Wechseln
-0.44 -0.19%
Monatlich
-6.24%
Jährlich
45.45%
Q2 Prognose
222.63




Nettoeinkommen Veränderung Datum
AbbVie USD 695M 1.12B 2026-03
Abbott USD 1.08B 699M 2026-03
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 3.08B 754M 2026-03
Baxter International USD -1.13B 1.08B 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Biogen USD 319.5M 368.4M 2026-03
Boston Scientific USD 1.34B 669M 2026-03
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
CONMED USD 16.74M 13.88M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Medtronic USD 1.14B 231M 2025-12
Merck USD 2.96B 2.82B 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Novartis USD 3.16B 747M 2026-03
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03
Zoetis USD 603M 118M 2025-12